Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 1,077.70
-8.25 (-0.76%)
At close: May 29, 2026
Zydus Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,084,418 | 876,631 | 891,926 | 1,013,630 | 497,549 | 356,774 | |
Market Cap Growth | 22.65% | -1.71% | -12.01% | 103.72% | 39.46% | -20.96% |
Enterprise Value | 1,162,162 | 930,186 | 892,181 | 1,022,435 | 525,557 | 387,118 |
Last Close Price | 1077.70 | 871.20 | 875.67 | 991.39 | 480.25 | 338.29 |
PE Ratio | 21.52 | 17.39 | 19.71 | 26.26 | 25.38 | 7.95 |
PS Ratio | 3.99 | 3.23 | 3.84 | 5.19 | 2.89 | 2.36 |
PB Ratio | 3.67 | 2.96 | 3.38 | 4.59 | 2.53 | 1.87 |
P/TBV Ratio | 11.18 | 9.03 | 5.76 | 8.48 | 4.28 | 3.40 |
P/FCF Ratio | - | - | 17.61 | 44.27 | 30.01 | 39.56 |
P/OCF Ratio | 51.23 | 41.42 | 13.16 | 31.71 | 18.50 | 16.95 |
EV/Sales Ratio | 4.28 | 3.43 | 3.84 | 5.23 | 3.05 | 2.56 |
EV/EBITDA Ratio | 15.80 | 12.82 | 13.06 | 19.45 | 14.87 | 12.21 |
EV/EBIT Ratio | 19.75 | 16.08 | 14.97 | 22.53 | 18.42 | 15.65 |
EV/FCF Ratio | -90.98 | - | 17.62 | 44.65 | 31.70 | 42.92 |
Debt / Equity Ratio | 0.42 | 0.42 | 0.12 | 0.04 | 0.06 | 0.22 |
Debt / EBITDA Ratio | 1.72 | 1.72 | 0.47 | 0.16 | 0.34 | 1.33 |
Debt / FCF Ratio | - | - | 0.64 | 0.36 | 0.72 | 4.68 |
Net Debt / Equity Ratio | 0.18 | 0.18 | -0.09 | -0.02 | 0 | 0.01 |
Net Debt / EBITDA Ratio | 0.73 | 0.73 | -0.35 | -0.10 | 0.00 | 0.08 |
Net Debt / FCF Ratio | -4.15 | -4.15 | -0.48 | -0.23 | 0.00 | 0.27 |
Asset Turnover | 0.61 | 0.61 | 0.70 | 0.71 | 0.64 | 0.59 |
Inventory Turnover | 1.52 | 1.52 | 1.77 | 1.87 | 1.81 | 1.64 |
Quick Ratio | 0.80 | 0.80 | 1.12 | 1.30 | 1.05 | 0.96 |
Current Ratio | 1.27 | 1.27 | 1.89 | 2.14 | 1.81 | 1.54 |
Return on Equity (ROE) | 18.32% | 18.32% | 19.28% | 18.90% | 10.82% | 13.96% |
Return on Assets (ROA) | 8.07% | 8.07% | 11.21% | 10.31% | 6.66% | 5.98% |
Return on Invested Capital (ROIC) | 13.47% | 15.00% | 20.11% | 17.64% | 11.43% | 10.78% |
Return on Capital Employed (ROCE) | 15.80% | 15.80% | 21.20% | 19.00% | 14.10% | 12.40% |
Earnings Yield | 4.65% | 5.75% | 5.07% | 3.81% | 3.94% | 12.58% |
FCF Yield | -1.18% | -1.46% | 5.68% | 2.26% | 3.33% | 2.53% |
Dividend Yield | 0.09% | 0.11% | 1.26% | 0.30% | 1.25% | 0.74% |
Payout Ratio | 21.95% | 21.95% | 6.68% | 16.09% | 13.63% | 8.29% |
Buyback Yield / Dilution | 0.00% | 0.00% | 0.56% | 0.37% | 0.79% | - |
Total Shareholder Return | 0.10% | 0.12% | 1.82% | 0.67% | 2.04% | 0.74% |